Remedium Bio raises $10M
Remedium Bio announced a Series A round of $10M on 10 August 2026. The company operates in HealthTech and is based in United States. It was founded by Frank Luppino, President & CEO.
Founder
Frank Luppino
President & CEO, Remedium Bio
Outreach angles
- -Frank Luppino previously served as Chief Operating Officer at Anika Therapeutics before becoming CEO of Remedium Bio.
- -He has spent his career leading regenerative-medicine and gene-therapy companies through clinical and commercial scale-up.
- -The $10 million Series A, backed by Eli Lilly and Lifespan Vision Ventures, will fund Remedium Bio's push toward first-in-human clinical studies.
Signals
Series AHealthcareDeep TechRegulated IndustryNew Market
Round details
Company: Remedium Bio
Domain: remedium-bio.com
Amount: $10M
Stage: Series A
Industry: HealthTech
Country: United States
Announced: 10 August 2026
Other HealthTech raises
Recently funded in United States